1 / 1

NHP002 [5.5 ± 1.24%]

A). Immunosuppression period. ***. 18. 16. *. 14. Hepatic PBGD activity (pmol URO/mg prot/h). 12. Normal range. 10. 8. 6. weeks. 0. 5. 10. 15. 20. 25. NHP001 w/o IS. NHP002 with IS. NHP003 with IS. **. 25. 20. PBGD expression mRNA (arbitrary units). 15. **. 10. *.

santo
Download Presentation

NHP002 [5.5 ± 1.24%]

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A) Immunosuppression period *** 18 16 * 14 Hepatic PBGD activity (pmol URO/mg prot/h) 12 Normal range 10 8 6 weeks 0 5 10 15 20 25 NHP001 w/o IS NHP002 with IS NHP003 with IS ** 25 20 PBGD expression mRNA (arbitrary units) 15 ** 10 * 5 0 0 non injected (n=4) NHP 001 NHP 002 NHP 003 x200 x200 x200 x200 x200 x200 B) C) NHP001 [2.2 ± 0.37%] NHP002 [5.5 ± 1.24%] NHP003 [2.2 ± 0.47%]

More Related